KinBio

Kin Bio

Pharmaceuticals, 2100 McKinney Ave Ste 850, Rehovot, Texas, 75201, United States, 11-50 Employees

kinbio.co.il

  • LinkedIn

phone no Phone Number: +12*********

Who is KINBIO

KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and develop...

Read More

map
  • 2100 McKinney Ave Ste 850, Rehovot, Texas, 75201, United States Headquarters: 2100 McKinney Ave Ste 850, Rehovot, Texas, 75201, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 6531 | NAICS Code: 531210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KINBIO

KinBio Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding KinBio

Answer: KinBio's headquarters are located at 2100 McKinney Ave Ste 850, Rehovot, Texas, 75201, United States

Answer: KinBio's phone number is +12*********

Answer: KinBio's official website is https://kinbio.co.il

Answer: KinBio's revenue is $1 Billion and Over

Answer: KinBio's SIC: 6531

Answer: KinBio's NAICS: 531210

Answer: KinBio has 11-50 employees

Answer: KinBio is in Pharmaceuticals

Answer: KinBio contact info: Phone number: +12********* Website: https://kinbio.co.il

Answer: KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics. Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis. Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products plants.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access